These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15025862)

  • 1. Effect of P-glycoprotein inhibition on methadone analgesia and brain distribution in the rat.
    Rodriguez M; Ortega I; Soengas I; Suarez E; Lukas JC; Calvo R
    J Pharm Pharmacol; 2004 Mar; 56(3):367-74. PubMed ID: 15025862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxycodone pharmacokinetics and pharmacodynamics in the rat in the presence of the P-glycoprotein inhibitor PSC833.
    Boström E; Simonsson US; Hammarlund-Udenaes M
    J Pharm Sci; 2005 May; 94(5):1060-6. PubMed ID: 15799017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling methadone pharmacokinetics in rats in presence of P-glycoprotein inhibitor valspodar.
    Ortega I; Rodriguez M; Suarez E; Perez-Ruixo JJ; Calvo R
    Pharm Res; 2007 Jul; 24(7):1299-308. PubMed ID: 17380267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of quinidine, used as a probe for the involvement of P-glycoprotein, on the intestinal absorption and pharmacodynamics of methadone.
    Kharasch ED; Hoffer C; Whittington D
    Br J Clin Pharmacol; 2004 May; 57(5):600-10. PubMed ID: 15089813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of omeprazole on oral and intravenous RS-methadone pharmacokinetics and pharmacodynamics in the rat.
    Carlos MA; Du Souich P; Carlos R; Suarez E; Lukas JC; Calvo R
    J Pharm Sci; 2002 Jul; 91(7):1627-38. PubMed ID: 12115824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simplified protocol employing elacridar in rodents: a screening model in drug discovery to assess P-gp mediated efflux at the blood brain barrier.
    Kallem R; Kulkarni CP; Patel D; Thakur M; Sinz M; Singh SP; Mahammad SS; Mandlekar S
    Drug Metab Lett; 2012 Jun; 6(2):134-44. PubMed ID: 23061481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of quinidine on antinociception and pharmacokinetics of morphine in rats.
    Okura T; Morita Y; Ito Y; Kagawa Y; Yamada S
    J Pharm Pharmacol; 2009 May; 61(5):593-7. PubMed ID: 19405997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased analgesia and alterations in distribution and metabolism of methadone by desipramine in the rat.
    Liu SJ; Wang RI
    J Pharmacol Exp Ther; 1975 Oct; 195(1):94-104. PubMed ID: 1181409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verapamil P-glycoprotein transport across the rat blood-brain barrier: cyclosporine, a concentration inhibition analysis, and comparison with human data.
    Hsiao P; Sasongko L; Link JM; Mankoff DA; Muzi M; Collier AC; Unadkat JD
    J Pharmacol Exp Ther; 2006 May; 317(2):704-10. PubMed ID: 16415090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinidine as a probe for the role of p-glycoprotein in the intestinal absorption and clinical effects of fentanyl.
    Kharasch ED; Hoffer C; Altuntas TG; Whittington D
    J Clin Pharmacol; 2004 Mar; 44(3):224-33. PubMed ID: 14973303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex specificity in methadone analgesia in the rat: a population pharmacokinetic and pharmacodynamic approach.
    Rodriguez M; Carlos MA; Ortega I; Suarez E; Calvo R; Lukas JC
    Pharm Res; 2002 Jun; 19(6):858-67. PubMed ID: 12134958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo evaluation of P-glycoprotein function at the blood-brain barrier in nonhuman primates using [11C]verapamil.
    Lee YJ; Maeda J; Kusuhara H; Okauchi T; Inaji M; Nagai Y; Obayashi S; Nakao R; Suzuki K; Sugiyama Y; Suhara T
    J Pharmacol Exp Ther; 2006 Feb; 316(2):647-53. PubMed ID: 16293715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duration and degree of cyclosporin induced P-glycoprotein inhibition in the rat blood-brain barrier can be studied with PET.
    Syvänen S; Blomquist G; Sprycha M; Höglund AU; Roman M; Eriksson O; Hammarlund-Udenaes M; Långström B; Bergström M
    Neuroimage; 2006 Sep; 32(3):1134-41. PubMed ID: 16857389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative investigation of the impact of P-glycoprotein inhibition on drug transport across blood-brain barrier in rats.
    Sugimoto H; Hirabayashi H; Kimura Y; Furuta A; Amano N; Moriwaki T
    Drug Metab Dispos; 2011 Jan; 39(1):8-14. PubMed ID: 20962062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a potent and specific P-glycoprotein inhibitor on the blood-brain barrier distribution and antinociceptive effect of morphine in the rat.
    Letrent SP; Pollack GM; Brouwer KR; Brouwer KL
    Drug Metab Dispos; 1999 Jul; 27(7):827-34. PubMed ID: 10383928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P-Glycoprotein mediates the efflux of quinidine across the blood-brain barrier.
    Kusuhara H; Suzuki H; Terasaki T; Kakee A; Lemaire M; Sugiyama Y
    J Pharmacol Exp Ther; 1997 Nov; 283(2):574-80. PubMed ID: 9353372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of inhibiting cytochrome P450 3A, p-glycoprotein, and gastric acid secretion on the oral bioavailability of methadone in dogs.
    Kukanich B; Lascelles BD; Aman AM; Mealey KL; Papich MG
    J Vet Pharmacol Ther; 2005 Oct; 28(5):461-6. PubMed ID: 16207309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833.
    Mayer U; Wagenaar E; Dorobek B; Beijnen JH; Borst P; Schinkel AH
    J Clin Invest; 1997 Nov; 100(10):2430-6. PubMed ID: 9366556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood-brain barrier transport of naloxone does not involve P-glycoprotein-mediated efflux.
    Suzuki T; Miyata M; Zaima C; Furuishi T; Fukami T; Kugawa F; Tomono K
    J Pharm Sci; 2010 Jan; 99(1):413-21. PubMed ID: 19530072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of P-glycoprotein activity at the primate blood-brain barrier increases the distribution of nelfinavir into the brain but not into the cerebrospinal fluid.
    Kaddoumi A; Choi SU; Kinman L; Whittington D; Tsai CC; Ho RJ; Anderson BD; Unadkat JD
    Drug Metab Dispos; 2007 Sep; 35(9):1459-62. PubMed ID: 17591677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.